Show simple item record

dc.contributor.authorSeyahi, E
dc.contributor.authorYurdakul, S
dc.contributor.authorFresko, I
dc.date.accessioned2021-03-04T10:33:05Z
dc.date.available2021-03-04T10:33:05Z
dc.date.issued2004
dc.identifier.citationFresko I., Seyahi E., Yurdakul S., "Infliximab and primary Sjogren's syndrome: Comment on the article by Mariette et al", ARTHRITIS AND RHEUMATISM, cilt.50, sa.12, ss.4077, 2004
dc.identifier.issn0004-3591
dc.identifier.othervv_1032021
dc.identifier.otherav_6dc74444-f14c-4c0f-85e8-49dc0e1fe5af
dc.identifier.urihttp://hdl.handle.net/20.500.12627/75820
dc.identifier.urihttps://doi.org/10.1002/art.20803
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleInfliximab and primary Sjogren's syndrome: Comment on the article by Mariette et al
dc.typeMakale
dc.relation.journalARTHRITIS AND RHEUMATISM
dc.contributor.department, ,
dc.identifier.volume50
dc.identifier.issue12
dc.identifier.startpage4077
dc.identifier.endpage4077
dc.contributor.firstauthorID8667


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record